IR
Superintel
Overview
Markets
Watchlist
More
G1 Therapeutics Inc
CUSIP: 3621LQ959 | 6 institutional holders
Watch
Quarters
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
All
Compare
Detailed
Historical
Funds
Options
Short Interest
13D/13G
Peers
Targeting
Trading Summary
Profile